T4	Subject 28 53	three individual patients
T5	Treatment 67 72;173 178	BTX-B BTX-B
T6	Effect 104 152	parasympathetic dysfunction of the visual system
T8	Population 28 33	three
T9	Drug 67 72	BTX-B
T10	Drug 173 178	BTX-B
T7	Adverse_event 94 103	developed
E1	Adverse_event:T7